Opiate addiction and overdose are a leading cause of death in the United States. Many people who have become addicted to opiates initially came across it within the normal parameters of temporary treatment for pain and discomfort, perhaps after a surgical procedure or unexpected injury. It can take as little as 5 days for the brain to become addicted and begin “over-interpreting” routine pain signals causing one to seek higher doses to manage symptoms. In addition, new onset of depression, hopelessness, anxiety, worry, and overthinking can emerge as one is consumed by the vicious spiral of chasing pain, leading to wanting higher amounts of pain drugs.

Buprenorphine/naloxone is the first FDA approved medication to treat opioid use disorder (OUD) that can be prescribed or dispensed in physician offices, significantly increasing access to treatment. Unlike other opiates, this unique drug was designed to treat cravings, prevent opioid withdrawal, and reduce abuse while offering freedom to engage in your daily living. Suboxone is intended for long term daily use, rather than “as needed.”